Anebulo Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview

Anebulo Pharmaceuticals

09/05/2025 13:33

Anebulo Pharmaceuticals Inc ANEB.OQ ANEB.O is expected to show no change in quarterly revenue when it reports  results on May 13 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Anebulo Pharmaceuticals Inc is for a loss of 5 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Anebulo Pharmaceuticals Inc is $8.00​, above​ its last closing price of $1.07. ​​​

This summary was machine generated May 9 at 12:33 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)